NPI: 1932553385 · JASPER, AL 35501 · General Acute Care Hospital · NPI assigned 04/21/2016
Authorized official MILLER, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | MILLER, JOHN (SVP OF FINANCE) |
| NPI Enumeration Date | 04/21/2016 |
Other providers sharing the same authorized official: MILLER, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,402 | $796K |
| 2019 | 37,370 | $733K |
| 2020 | 21,855 | $421K |
| 2021 | 27,474 | $530K |
| 2022 | 33,553 | $978K |
| 2023 | 45,331 | $1.58M |
| 2024 | 19,092 | $878K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,713 | 5,312 | $1.70M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 20,999 | 18,364 | $1.26M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,513 | 17,489 | $701K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,151 | 1,787 | $288K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,156 | 2,691 | $229K |
| D9420 | 1,233 | 754 | $229K | |
| 80053 | Comprehensive metabolic panel | 18,402 | 15,461 | $171K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 20,624 | 17,395 | $158K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,299 | 4,077 | $155K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,634 | 2,415 | $154K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,200 | 2,770 | $125K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,981 | 2,558 | $89K |
| 87088 | 8,604 | 7,422 | $75K | |
| 87430 | 4,646 | 4,348 | $70K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,962 | 5,723 | $67K |
| 71045 | Radiologic examination, chest; single view | 10,348 | 8,863 | $51K |
| 81001 | 13,217 | 11,169 | $46K | |
| 84484 | 5,208 | 4,073 | $38K | |
| 87081 | 3,843 | 3,619 | $36K | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 51 | 28 | $30K |
| 83690 | 5,361 | 4,485 | $29K | |
| 87400 | 5,294 | 4,722 | $26K | |
| 81025 | 7,745 | 6,736 | $22K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,666 | 3,066 | $20K |
| 59025 | Fetal non-stress test | 3,606 | 2,415 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 319 | 313 | $16K |
| 83735 | 1,930 | 1,581 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | 936 | 885 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 269 | 234 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 817 | 734 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | 97 | 78 | $7K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 344 | 337 | $6K |
| 81003 | 2,438 | 2,065 | $5K | |
| 87420 | 321 | 312 | $5K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 12 | 12 | $5K |
| 83880 | 242 | 202 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 353 | 338 | $4K |
| 85610 | 849 | 716 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,130 | 3,291 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 59 | 50 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 129 | 119 | $3K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 19 | 14 | $2K |
| J2704 | Injection, propofol, 10 mg | 2,355 | 1,632 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,776 | 2,088 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,248 | 1,086 | $2K |
| 82550 | 304 | 274 | $2K | |
| 87186 | 186 | 172 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 28 | 28 | $2K |
| 84100 | 386 | 303 | $1K | |
| 87040 | 108 | 83 | $965.37 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,158 | 6,649 | $838.01 |
| 87077 | 81 | 74 | $660.45 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 457 | 353 | $622.20 |
| 84112 | 16 | 12 | $570.16 | |
| 74018 | 55 | 52 | $555.66 | |
| 84702 | 39 | 38 | $518.76 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 216 | 179 | $493.15 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 56 | 40 | $481.75 |
| 83605 | 65 | 54 | $476.68 | |
| 85730 | 286 | 226 | $444.01 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 18 | 13 | $429.00 |
| 73564 | 26 | 24 | $357.20 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 12 | 12 | $280.90 |
| 82150 | 45 | 40 | $257.41 | |
| 73610 | 15 | 13 | $212.24 | |
| 73630 | 14 | 13 | $181.92 | |
| 73130 | 12 | 12 | $127.50 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 67 | 61 | $98.40 |
| 86850 | 15 | 14 | $91.65 | |
| 86900 | 15 | 14 | $42.77 | |
| 86901 | 15 | 14 | $42.38 | |
| 88304 | 60 | 58 | $25.59 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 96 | 84 | $14.87 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 62 | 46 | $6.10 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 331 | 252 | $2.86 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 5,148 | 3,706 | $0.01 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 615 | 561 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 14 | 14 | $0.00 |
| 0240U | 1,686 | 1,495 | $0.00 | |
| 41899 | Unlisted procedure, dentoalveolar structures | 205 | 192 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 36 | 26 | $0.00 |
| 80320 | 13 | 13 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 17 | 12 | $0.00 |